Dr Kate Stringaris is a Consultant Haematologist and Clinician Scientist, currently practising at University College London Hospital. She specialises in treating blood disorders through chemotherapy, cellular therapies, and stem cell transplantation. Dr Stringaris earned her primary medical degree from University College London and completed her general medical training at St George’s Hospital. She completed her specialist training in haematology at the Royal Free Hospital and Hammersmith Hospitals in London.

Dr Stringaris attained her PhD on Leukaemia from Imperial College London and previously served as a Senior Clinical Lecturer at St Bart’s Hospital in London. Her research focuses on immune defects in leukaemia and transplantation immunology. She worked for 4 years as a senior research physician at the National Heart Lung and Blood Institute, National Institutes of Health in the USA, where she concentrated on natural killer cell immunity and pioneering immune therapies for acute myeloid leukaemia.

Appointed as a Consultant Haematologist in 2014, Dr Stringaris is dedicated to advancing the field of haematology through both clinical practice and research. Her areas of expertise include chemotherapy, cellular therapies and immune therapies including stem cell transplantation. She is particularly interested in the treatment of acute myeloid leukaemia and the development of innovative therapies to improve patient outcomes.